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Cardio-Oncology: Success Breeds New Challenges, Opportunities
Charles A. Bomzer, MD, Bijoy K. Khandheria, MD, Co-Directors, Aurora Center for Cardio-Oncology Research
and Innovation, Milwaukee, WI │ Editorial

The burgeoning field of cardio-oncology is a story of
success on many different fronts. Advances in medical
oncology, including the development of new agents and
the development of new ways of combining antineoplastic
treatments, have resulted in improved survival rates. These
advances have created whole new classes of drugs with
unexpected toxicities when given as single agents and when
combined with other agents. The improvement in survival,
in turn, has allowed the latency of delayed side effects to
become manifest in these individuals. Improvements in
patient survival also have changed the natural history of some
cancers, leading to unusual patterns of metastases. Advances
in the field of cardiology have improved our understanding
of the mechanisms of cardiomyocyte damage, the physiology
of heart failure, and the arrhythmogenicity of drugs. Such
advances have led to advances in cardiodiagnostics, imaging,
and the prevention and care of heart failure. Moving forward
together, these two seemingly disparate subspecialties –
medical oncology and cardiology – have forged new bonds
and close working relations, a collaboration that has created
opportunities to improve the care of our patients in hitherto
unanticipated ways. The articles in this issue of Journal of
Patient-Centered Research and Reviews provide a glimpse
into several aspects of this new and exciting field.
The article by Dr. Pizzino and colleagues provides an
overview of the new techniques being employed to diagnose
and predict cardiac dysfunction.1 The authors review the pros
and cons of various modalities and discuss the pragmatic
application of them. Their discussion includes insights into
the issues of availability and cost, both of which are important
considerations in the real-world use of these modalities.
The article by Dr. Gul and colleagues discusses the unusual
presentation of an increasingly more common malignancy,
malignant melanoma.2 Although clinically manifest cardiac
metastases are not common in this malignancy, new
treatments such as ipilimumab and vemurafinib have the
potential to alter the natural history of this malignancy and
render previously uncommon metastatic sites more common.
The discussion of the cardiovascular toxicities of
chemotherapeutic agents employed in the treatment of breast
cancer, which we have provided on page 133, introduces the
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reader to the potential risks entailed in treating one of the
more common malignancies.3 It briefly reviews the drugs and
the likelihoods of the more frequent cardiotoxicities as well
as providing reassurance of the infrequent risks associated
with most of these agents.
Rounding out this issue’s cancer-related topics, Ms. Waltke
provides a discussion of the benefits of rehabilitation and
exercise therapy in the management of patients with cancer.4
This often-overlooked area is gaining prominence as an
adjunct to the treatment of cancer patients, with a growing
body of literature to support its benefits. As a national leader
in cancer rehabilitation, Ms. Waltke’s contributions keep us
on the cutting edge of this field.
As guest editors, it is our hope you will gain a greater insight
into this exciting area after reading the articles in this issue.
We have certainly enjoyed working with the editor-in-chief
of Journal of Patient-Centered Research and Reviews and
its editorial board in putting this issue together.
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